Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).

Centers for Medicare & Medicaid Services

LOCAL COVERAGE DETERMINATION

LCD for NON-INVASIVE VASCULAR DIAGNOSTIC STUDIES (L3743)

Contractor Information

 

Contractor Name 

National Government Services, Inc.  

Contractor Number 

00803 

Contractor Type 

Carrier 

LCD Information

 

LCD ID Number 

L3743 

 

LCD Title 

NON-INVASIVE VASCULAR DIAGNOSTIC STUDIES 

 

Contractor's Determination Number 

 
 

AMA CPT / ADA CDT Copyright Statement 

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.  

 

CMS National Coverage Policy 

  • Title XVIII of the Social Security Act, Section 1862 (a)(7)
    This section excludes routine physical examinations.
  • Title XVIII of the Social Security Act, Section 1862 (a)(1)(A)
    This section allows coverage and payment for only those services considered medically reasonable and necessary.
  • Title XVIII of the Social Security Act, Section 1833 (e)
    This section prohibits Medicare payment for any claim which lacks the necessary information to process the claim.
  • CMS Manual System, Pub 100-3, National Coverage Determinations, Chapter 1 Section 20.14
    This section covers payable procedures and indications for plethysmography.
  • CMS Manual System, Pub 100-3, National Coverage Determinations, Chapter 1 Section 220.5
    This section covers payable procedures and indications for ultrasound diagnostic procedures.
  • CMS Transmittal AB-00-44
    This program memorandum defines coverage of vascular studies for ESRD patients.
  • CMS Transmittal AB-01-129 for CR 1855
    This Program Memorandum defines Medicare coverage of Non-Invasive Vascular Studies for ESRD patients.
  • Program Memorandum, Transmittal AB-02-085 (CR 2194).
    Medicare Contractor Annual Update of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
 

Primary Geographic Jurisdiction 

New York - Downstate
 

 

Oversight Region 

Region II
 

 
 

Original Determination Effective Date 

For services performed on or after 11/01/1999  

 

Original Determination Ending Date 

 
 

Revision Effective Date 

For services performed on or after 01/01/2008  

 

Revision Ending Date 

 
 

Indications and Limitations of Coverage and/or Medical Necessity 

Non-invasive vascular diagnostic studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two-dimensional image with spectral analysis and color flow or a plethysmographic recording that allows for quantitation analysis.

Vascular studies include patient care required to perform the studies, supervision of the studies and interpretation of study results with copies for patient records of hard copy output or imaged when provided.

The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and interpreter. Consequently, the providers of interpretations must be capable of demonstrating documented training and experience and maintain documentation for post-payment audit.

Effective January 1, 1999, all non-invasive vascular diagnostic studies must be performed under at least one of the following settings: (1) performed by a physician who is competent in diagnostic vascular studies or under the general supervision of physicians who have demonstrated minimum entry level competency by being credentialed in vascular technology, or (2) performed by a technician who is certified in vascular technology, or (3) performed in facilities with laboratories accredited in vascular technology.

Examples of appropriate personnel certification include, but are not limited to the Registered Vascular Technologist (RCT), the Registered Cardiovascular Technologist (RCVT) and the American Registry of Radiologic Technologists (ARRT) credentials in vascular technology. Appropriate laboratory accreditation includes the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL).

Definitions:

·  A duplex scan implies an ultrasonic scanning procedure with display of both two-dimensional structure and motion with time and Doppler ultrasonic signal documentation with spectrum analysis and/or color flow velocity mapping or imaging.

·  A physiologic study implies functional measurement procedures including Doppler ultrasound studies, blood pressure measurements, transcutaneous oxygen tension measurements or plethysmography.

·  Plethysmography implies volume measurement procedures including air, impedance, or strain gauge methods.

·  Transcranial Doppler uses ultrasound principles to emit high frequency soundwaves from a Doppler device to detect the flow of blood or pinpoint an arterial irregularity such as an obstruction in the arteries within the cranium (skull).

General Indications

- Non-invasive vascular studies are used for the evaluation of patients with either arterial or venous diseases. The studies are often used prior to invasive studies or to define surgical intervention.

General Limitations

·  The services outlined in this policy will not be covered if they are performed using simple hand held or other doppler devices that do not produce hard copy output, or devices that do not permit analysis of the bi-directional vascular flow or doppler procedures performed with zero-crossers (i.e. analog [strip chart recorder] analysis).

·  Medicare does not pay for routine screening tests. ICD-9-CM diagnosis code V82.9 (special screening of other conditions, unspecified condition) should be used to indicate screening tests performed in the absence of a specific sign, symptom, or complaint. Use of ICD-9-CM code V82.9 will result in the denial of claims as non-covered screening services.

·  It is seldom necessary to perform arterial and venous studies during the same encounter. Documentation should be available to support the medical necessity for both studies.

·  The Correct Coding Initiative precludes billing codes 93925, 93926, 93930, 93931, 93970, and 93971 on the same day as HCPCS code G0365. It also precludes billing HCPCS code G0365 on the same day as codes 93922,93923, and 93965.

·  It is rarely necessary to perform cerebrovascular and upper extremity studies on the same day. Documentation supporting the need for both studies should be available for review.

·  A referral must be on record for each non-invasive study performed. A referral for one type of study does not qualify as a referral for all tests.

CEREBROVASCULAR ARTERIAL STUDIES (codes 93875-93892)

Indications:

Cerebrovascular arterial studies are considered for Medicare payment when at least one of the following conditions is present:

- Cervical bruits
- Amaurosis fugax
- Focal cerebral or ocular transient ischemic attacks (including but not limited to localizing symptoms, weakness of one side of the face, slurred speech, weakness of a limb, ocular microembolism, arterial occlusions on retinal examination (branch or central), optic nerve/retinal/ocular ischemia, suspected dural or carotid cavernous fistulae).
- Drop attacks or syncope are rare indications primarily seen with vertebrobasilar or bilateral carotid artery disease.
- Episodic dizziness with symptom characteristics typical of transient ischemic attacks, especially when other more common sources (e.g., postural hypotension or transiently decreased cardiac output as demonstrated by cardiac events monitoring) have been previously excluded.
- Cerebral vasospasm complicating subarachnoid hemorrhage
- Impending invasive therapeutic interventions for cerebral arteriovenous malformations
- Intracranial hemodynamic abnormalities in patients with suspected brain death
- Intraoperative and perioperative monitoring of intracranial flow velocity and hemodynamic patterns during carotid endarterectomy (This is usually a Part A responsibility, unless the professional component is performed by a physician who is not a member of the operating team.)
- Cerebral embolization
- Evaluation and follow-up of asymptomatic bruits

Limitations:

The following conditions would not meet medical necessity criteria for coverage:

- Headaches (including migraines)
- Dizziness, unless associated with other localizing symptoms
- Assessment of familial and degenerative diseases of the cerebrum, brainstem, cerebellum, basal ganglia and motor neurons
- Epilepsy
- Psychiatric disorders
- Brain tumors
- Evaluation of infectious and inflammatory conditions

The following conditions are considered investigational applications and are not covered:

- Migraine
- Monitoring during carotid endarterectomy, cardiopulmonary bypass and other cerebrovascular and cardiovascular interventions.
- Evaluation of patients with dilated vasculopathies such as fusiform aneurysms
- Assessing autoregulation, physiologic, and pharmacological responses of cerebral arteries

PERIPHERAL ARTERIAL EXAMINATIONS (codes 93922-93931)

Indications

Peripheral arterial studies are considered for Medicare coverage when there are significant signs and/or symptoms of possible limb ischemia in a patient who may be a candidate for invasive therapeutic procedures, as indicated by at least one of these conditions:

- Claudication of such severity that it interferes significantly with the patient’s occupation or lifestyle.
- Rest pain (typically including the forefoot) usually associated with absent pulses, which becomes increasingly severe with elevation and diminishes with placement of the leg in a dependent position.
- Tissue loss defined as gangrene or pregangrenous changes of the extremity, or ischemic ulceration of the extremity occurring in the absence of pulses.
- Aneurysmal disease
- Evidence of thromboembolic events
- Blunt or penetrating trauma (including complications of diagnostic and/or therapeutic procedures
- Follow-up grafts

Limitations:

1. The following conditions would not meet medical necessity criteria for coverage:

  • "Leg pain, nonspecific" and "pain in limb" as a single diagnosis is too general to warrant further investigation unless they are related to other signs and symptoms.
  • Edema rarely occurs with arterial occlusive disease unless it is the immediate postoperative period, in association with another inflammatory process or in association with rest pain.
  • Absence of relatively minor pulses (such as isolated dorsalis pedis or posterior tibial) in the absence of symptoms is not an indication to proceed beyond the physical examination unless it is related to other signs or symptoms.


2. Calculation of the ankle/brachial index (ABI) is considered to be part of the peripheral vascular study, and is therefore not separately payable. If the provider uses a device that does not meet the specifications for coverage outlined in the “General Limitations” section of the LCD, the determination of the ABI should be added to the amount and complexity of data in the medical decision making portion of the E&M service.

PERIPHERAL VENOUS EXAMINATIONS (codes 93965-93971)

Indications

These studies are medially necessary in patients who are candidates for anticoagulation, thrombolysis, or invasive therapeutic procedures and who have signs or symptoms of one of the following:

- Deep vein thrombosis (DVT) indicated by edema, tenderness, inflammation, and/or erythema
- Pulmonary embolism (PE) indicated by hemoptysis, chest pain, and/or dyspnea
- Unexplained lower extremity edema status-post major surgical procedures
- Chronic venous insufficiency indicated by secondary varicose veins
- Post-thrombotic (post-phlebitic) syndrome
- Ulceration suspected to be secondary to venous insufficiency
- Primary varicose veins with symptoms (e.g., pain, swelling)
- Venous mapping for the selection of a vein suitable for creating a dialysis fistula or prior to revascularization by reducing the time necessary for the surgery.

Note:

Venous mapping is not always indicated as a routine pre-operative study. However, if the patient’s clinical evaluation does not readily lead to the selection of a vein that is suitable for creating a dialysis fistula, the venous mapping would be considered medically necessary. This procedure may also be useful prior to revascularization by reducing the time necessary for the surgery. Effective for services performed on or after June 1, 1999, is considered a covered service in either of these situations when performed once prior to the surgical procedure (i.e., hemodialysis site being surgically created or revascularization). In either situation, procedure code 93990/G0365 should be reported with ICD-9-CM code V72.83. When this service is performed in a hospital setting, only the professional component (modifier 26) should be billed to Medicare Part B.



Limitations

The following conditions would not meet medical necessity criteria for coverage:

- It is not medically necessary to perform duplex scans (93970, 93971) and physiological tests (93965) during the same encounter.
- Bilateral limb edema in the presence of signs and/or symptoms of congestive heart failure, exogenous obesity and/or arthritis should rarely be an indication.
- It is not medically necessary to perform peripheral venous examinations to study primary varicose veins that are not symptomatic.

VISCERAL VASCULAR STUDIES (93975, 93976, 93978, 93979)

Indications

Visceral vascular studies are considered for Medicare payment when one of the following conditions is present:

- Arteriosclerosis of renal artery
- Aortic aneurysm and dissection
- Peripheral vascular disease
- Intestinal vascular insufficiency
- Intestinal angiodysplasia (this indication requires expert hands with selective ICAVL accreditation)

NOTE:For procedure codes 93980 and 93981 and for diagnosis of erectile dysfunction, refer to Empire's policy YSURG #27.

HEMODIALYSIS ACCESS EXAMINATION (HCPCS code 93990)

Indications:
Medicare will consider separate payment for vascular studies ( CPT code 93990) on symptomatic ESRD patients, when Doppler flow studies are used to provide diagnostic information to determine the appropriate medical intervention. Medicare considers a Doppler flow study medically necessary when the beneficiary’s dialysis access site manifests signs or symptoms associated with vascular compromise, and when the results of this test are necessary to determine the clinical course of treatment.

Signs or symptoms in patients with ESRD of impending failure of the hemodialysis access site, including:

- Elevated venous pressure > 200mm HG on a 200 cc/min. pump
- Elevated recirculation of time of 12 percent or greater, and
- Low urea reduction rate < 60 percent
- An access with a palpable "water hammer" pulse on examination (which implies venous outflow obstruction)

VESSEL MAPPING OF VESSELS FOR HEMODIALYSIS ACCESS (HCPCS CODE G0365)

Indications:
Vessel mapping of vessels for hemodialysis access is considered for Medicare payment when it is performed preoperatively prior to creation of hemodiaysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow.

Limitations:

·  Medicare will limit payment to either a Doppler flow study (93990) or an angiogram (fistulogram, venogram, 75790 with 36145 or 75820 with 36005), but not both, unless documentation is provided to support the medical necessity for both studies.

An example of a clinical situation demonstrating the need for both studies would be a scenario where a Doppler flow study demonstrates reduced flow (blood flow rate less than 800cc/min or a decreased flow of 25% or greater from previous study), and the physician requires an arteriogram, to define the extent of the problem. The patient's medical record(s) must provide documentation supporting the need for more than one imaging study.

·  If the service is done for monitoring purposes, it is not covered under Part B.

·  No separate payment for non-invasive vascular studies for monitoring the access site of an ESRD patient, whether coded as the access site or peripheral site, is permitted to any entity.

·  The technical component of HCPCS code G0365 and CPT code 93990 (modifier TC) performed in ESRD facilities or for ESRD patients is included in the composite payment rate. This rate is a comprehensive payment that includes all services, equipment, supplies and certain laboratory tests and drugs that are necessary for dialysis treatment.

·  The professional component for the procedure (modifier 26) is included in the monthly capitation payment (MCP) if billed by the MCP physician. Physicians other than the MCP provider may bill separately for interpretations of tests.

·  Services performed on ESRD patients by entities outside the ESRD facility must bill the ESRD facility for payment.

·  Unless documentation is provided supporting the necessity of more than one study, Medicare will limit payment to either a Doppler flow study (CPT code 93990/HCPCS code G0365) or an arteriogram (fistulogram, venogram,-CPT codes 75790/75820), but not both.
 

 

Coverage Topic 

Diagnostic Tests and X-Rays
 

Coding Information

 

Bill Type Codes: 

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

 
 

Revenue Codes: 

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

99999

Not Applicable

 

CPT/HCPCS Codes 

Cerebrovascular Arterial Studies

93875

Extracranial study

93880

Extracranial study

93882

Extracranial study

93886

Intracranial study

93888

Intracranial study

93890

Tcd, vasoreactivity study

93892

Tcd, emboli detect w/o inj

93893

Tcd, emboli detect w/inj

Extremity Arterial Studies

93922

Extremity study

93923

Extremity study

93924

Extremity study

93925

Lower extremity study

93926

Lower extremity study

93930

Upper extremity study

93931

Upper extremity study

Extremity Venous Studies

93965

Extremity study

93970

Extremity study

93971

Extremity study

Visceral Vascular Studies

Note: For Empire Medicare Services, for procedure codes 93980 and 93981 and erectile dysfunction diagnoses, refer to policy L9426 (NY) and L3558 (NJ)- Impotence (Erectile Dysfunction, Evaluation, and Management).

93975

Vascular study

93976

Vascular study

93978

Vascular study

93979

Vascular study

Extremity Arterial-Venous Studies

93990

Doppler flow testing

G0365

Vessel mapping hemo access

 

ICD-9 Codes that Support Medical Necessity 

TRUNCATED DIAGNOSIS CODES ARE NOT ACCEPTABLE.

ICD-9-CM code listings may cover a range and include truncated codes. It is the provider’s responsibility to avoid truncated codes by selecting a code(s) carried out to the highest level of specificity and selected from the ICD-9-CM book appropriate to the year in which the service was performed.

It is not enough to link the procedure code to a correct, payable ICD-9-CM code. The diagnosis or clinical signs/symptoms must be present for the procedure to be paid.
Further, these ICD-9-CM codes can be used only with the conditions listed in the Indications and Limitations sections of this policy.

CEREBROVASCULAR ARTERIAL STUDIES (93875, 93880, 93882, 93886, 93888, 93890, 93892, 93893)

342.01

FLACCID HEMIPLEGIA AND HEMIPARESIS AFFECTING DOMINANT SIDE

342.02

FLACCID HEMIPLEGIA AND HEMIPARESIS AFFECTING NONDOMINANT SIDE

342.11

SPASTIC HEMIPLEGIA AND HEMIPARESIS AFFECTING DOMINANT SIDE

342.12

SPASTIC HEMIPLEGIA AND HEMIPARESIS AFFECTING NONDOMINANT SIDE

342.81

OTHER SPECIFIED HEMIPLEGIA AND HEMIPARESIS AFFECTING DOMINANT SIDE

342.82

OTHER SPECIFIED HEMIPLEGIA AND HEMIPARESIS AFFECTING NONDOMINANT SIDE

344.01

QUADRIPLEGIA C1-C4 COMPLETE

344.02

QUADRIPLEGIA C1-C4 INCOMPLETE

344.03

QUADRIPLEGIA C5-C7 COMPLETE

344.04

QUADRIPLEGIA C5-C7 INCOMPLETE

344.09

OTHER QUADRIPLEGIA

344.1

PARAPLEGIA

344.2

DIPLEGIA OF UPPER LIMBS

344.31

MONOPLEGIA OF LOWER LIMB AFFECTING DOMINANT SIDE

344.32

MONOPLEGIA OF LOWER LIMB AFFECTING NONDOMINANT SIDE

344.41

MONOPLEGIA OF UPPER LIMB AFFECTING DOMINANT SIDE

344.42

MONOPLEGIA OF UPPER LIMB AFFECTING NONDOMINANT SDE

362.31

CENTRAL RETINAL ARTERY OCCLUSION

362.32

RETINAL ARTERIAL BRANCH OCCLUSION

362.33

PARTIAL RETINAL ARTERIAL OCCLUSION

362.34

TRANSIENT RETINAL ARTERIAL OCCLUSION

362.35

CENTRAL RETINAL VEIN OCCLUSION

362.36

VENOUS TRIBUTARY (BRANCH) OCCLUSION OF RETINA

362.37

VENOUS ENGORGEMENT OF RETINA

362.84

RETINAL ISCHEMIA

368.10

SUBJECTIVE VISUAL DISTURBANCE UNSPECIFIED

368.11

SUDDEN VISUAL LOSS

368.12

TRANSIENT VISUAL LOSS

368.2

DIPLOPIA

368.41

SCOTOMA INVOLVING CENTRAL AREA

368.42

SCOTOMA OF BLIND SPOT AREA

368.43

SECTOR OR ARCUATE VISUAL FIELD DEFECTS

368.44

OTHER LOCALIZED VISUAL FIELD DEFECT

368.45

GENERALIZED VISUAL FIELD CONTRACTION OR CONSTRICTION

368.46

HOMONYMOUS BILATERAL FIELD DEFECTS

368.47

HETERONYMOUS BILATERAL FIELD DEFECTS

386.2

VERTIGO OF CENTRAL ORIGIN

430

SUBARACHNOID HEMORRHAGE

433.00

OCCLUSION AND STENOSIS OF BASILAR ARTERY WITHOUT CEREBRAL INFARCTION

433.01

OCCLUSION AND STENOSIS OF BASILAR ARTERY WITH CEREBRAL INFARCTION

433.10

OCCLUSION AND STENOSIS OF CAROTID ARTERY WITHOUT CEREBRAL INFARCTION

433.11

OCCLUSION AND STENOSIS OF CAROTID ARTERY WITH CEREBRAL INFARCTION

433.20

OCCLUSION AND STENOSIS OF VERTEBRAL ARTERY WITHOUT CEREBRAL INFARCTION

433.21

OCCLUSION AND STENOSIS OF VERTEBRAL ARTERY WITH CEREBRAL INFARCTION

433.30

OCCLUSION AND STENOSIS OF MULTIPLE AND BILATERAL PRECEREBRAL ARTERIES WITHOUT CEREBRAL INFARCTION

433.31

OCCLUSION AND STENOSIS OF MULTIPLE AND BILATERAL PRECEREBRAL ARTERIES WITH CEREBRAL INFARCTION

433.80

OCCLUSION AND STENOSIS OF OTHER SPECIFIED PRECEREBRAL ARTERY WITHOUT CEREBRAL INFARCTION

433.81

OCCLUSION AND STENOSIS OF OTHER SPECIFIED PRECEREBRAL ARTERY WITH CEREBRAL INFARCTION

433.90

OCCLUSION AND STENOSIS OF UNSPECIFIED PRECEREBRAL ARTERY WITHOUT CEREBRAL INFARCTION

433.91

OCCLUSION AND STENOSIS OF UNSPECIFIED PRECEREBRAL ARTERY WITH CEREBRAL INFARCTION

434.00

CEREBRAL THROMBOSIS WITHOUT CEREBRAL INFARCTION

434.01

CEREBRAL THROMBOSIS WITH CEREBRAL INFARCTION

434.10

CEREBRAL EMBOLISM WITHOUT CEREBRAL INFARCTION

434.11

CEREBRAL EMBOLISM WITH CEREBRAL INFARCTION

434.90

CEREBRAL ARTERY OCCLUSION UNSPECIFIED WITHOUT CEREBRAL INFARCTION

434.91

CEREBRAL ARTERY OCCLUSION UNSPECIFIED WITH CEREBRAL INFARCTION

435.0

BASILAR ARTERY SYNDROME

435.1

VERTEBRAL ARTERY SYNDROME

435.2

SUBCLAVIAN STEAL SYNDROME

435.3

VERTEBROBASILAR ARTERY SYNDROME

435.8

OTHER SPECIFIED TRANSIENT CEREBRAL ISCHEMIAS

435.9

UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA

436

ACUTE BUT ILL-DEFINED CEREBROVASCULAR DISEASE

437.0

CEREBRAL ATHEROSCLEROSIS

437.1

OTHER GENERALIZED ISCHEMIC CEREBROVASCULAR DISEASE

437.3

CEREBRAL ANEURYSM NONRUPTURED

437.4

CEREBRAL ARTERITIS

437.7

TRANSIENT GLOBAL AMNESIA

442.81

ANEURYSM OF ARTERY OF NECK

442.82

ANEURYSM OF SUBCLAVIAN ARTERY

443.21

DISSECTION OF CAROTID ARTERY

443.24

DISSECTION OF VERTEBRAL ARTERY

780.2

SYNCOPE AND COLLAPSE

781.2

ABNORMALITY OF GAIT

781.3

LACK OF COORDINATION

781.4

TRANSIENT PARALYSIS OF LIMB

781.94

FACIAL WEAKNESS

782.0

DISTURBANCE OF SKIN SENSATION

784.3

APHASIA

784.5

OTHER SPEECH DISTURBANCE

785.9

OTHER SYMPTOMS INVOLVING CARDIOVASCULAR SYSTEM

900.01

INJURY TO COMMON CAROTID ARTERY

900.02

INJURY TO EXTERNAL CAROTID ARTERY

900.03

INJURY TO INTERNAL CAROTID ARTERY

900.1

INJURY TO INTERNAL JUGULAR VEIN

901.1

INJURY TO INNOMINATE AND SUBCLAVIAN ARTERIES

996.1

MECHANICAL COMPLICATION OF OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.70

OTHER COMPLICATIONS DUE TO UNSPECIFIED DEVICE IMPLANT AND GRAFT

996.71

OTHER COMPLICATIONS DUE TO HEART VALVE PROSTHESIS

996.72

OTHER COMPLICATIONS DUE TO OTHER CARDIAC DEVICE IMPLANT AND GRAFT

996.73

OTHER COMPLICATIONS DUE TO RENAL DIALYSIS DEVICE IMPLANT AND GRAFT

996.74

OTHER COMPLICATIONS DUE TO OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.75

OTHER COMPLICATIONS DUE TO NERVOUS SYSTEM DEVICE IMPLANT AND GRAFT